Cargando…

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR

OBJECTIVES: Activation of the bile acid (BA) receptors farnesoid X receptor (FXR) or G protein-coupled bile acid receptor (GPBAR1; TGR5) improves metabolic homeostasis. In this study, we aim to determine the impact of pharmacological activation of bile acid receptors by INT-767 on reversal of diet-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jadhav, Kavita, Xu, Yang, Xu, Yanyong, Li, Yuanyuan, Xu, Jiesi, Zhu, Yingdong, Adorini, Luciano, Lee, Yoon Kwang, Kasumov, Takhar, Yin, Liya, Zhang, Yanqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870099/ https://www.ncbi.nlm.nih.gov/pubmed/29361497 http://dx.doi.org/10.1016/j.molmet.2018.01.005

Ejemplares similares

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes
por: Xu, Yanyong, et al.
Publicado: (2019)

Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice
por: Iracheta‐Vellve, Arvin, et al.
Publicado: (2018)

Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Miyata, Sachiho, et al.
Publicado: (2021)

The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
por: Wang, Xiaoxin X., et al.
Publicado: (2022)

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism
por: Xu, Yanyong, et al.
Publicado: (2021)

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury
por: Xu, Jiesi, et al.
Publicado: (2016)

Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5
por: Trammell, Samuel A. J., et al.
Publicado: (2020)

Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr(−/−) mice
por: Xu, Jiesi, et al.
Publicado: (2017)

Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain
por: Wu, Yuning, et al.
Publicado: (2023)

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
por: Baars, Annemarie, et al.
Publicado: (2015)

Blueberry Extract Improves Obesity through Regulation of the Gut Microbiota and Bile Acids via Pathways Involving FXR and TGR5
por: Guo, Jielong, et al.
Publicado: (2019)

FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
por: Kang, Ju-Hee, et al.
Publicado: (2021)

Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
por: Miyazaki-Anzai, Shinobu, et al.
Publicado: (2014)

Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
por: Han, Bing, et al.
Publicado: (2023)

The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic syndrome
por: Stepanov, Vanesa, et al.
Publicado: (2012)

A Metabolic Stress-inducible miR-34a-HNF4α Pathway Regulates Lipid and Lipoprotein Metabolism
por: Xu, Yang, et al.
Publicado: (2015)

Hepatocyte‐Specific Expression of Human Carboxylesterase 1 Attenuates Diet‐Induced Steatohepatitis and Hyperlipidemia in Mice
por: Xu, Yanyong, et al.
Publicado: (2020)

Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
por: Kim, Hyeonhui, et al.
Publicado: (2018)

Central anorexigenic actions of bile acids are mediated by TGR5
por: Perino, Alessia, et al.
Publicado: (2021)

Hepatic Carboxylesterase 1 Is Induced by Glucose and Regulates Postprandial Glucose Levels
por: Xu, Jiesi, et al.
Publicado: (2014)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis
por: Zhu, Yingdong, et al.
Publicado: (2023)

Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity
por: Münzker, Julia, et al.
Publicado: (2022)

Multigenerational impacts of bile exposure are mediated by TGR5 signaling pathways
por: Baptissart, Marine, et al.
Publicado: (2018)

The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
por: Qi, Youchao, et al.
Publicado: (2022)

Megatrends in bile acid receptor research
por: Adorini, Luciano, et al.
Publicado: (2017)

Deciphering the nuclear bile acid receptor FXR paradigm
por: Modica, Salvatore, et al.
Publicado: (2010)

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
por: Noel, Olivier F., et al.
Publicado: (2016)

Bile Acids and FXR: Novel Targets for Liver Diseases
por: Stofan, Mary, et al.
Publicado: (2020)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
por: Lou, Guiyu, et al.
Publicado: (2014)

TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
por: Bidault-Jourdainne, Valeska, et al.
Publicado: (2020)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

Impact of bile acids on the growth of human cholangiocarcinoma via FXR
por: Dai, Jiaqi, et al.
Publicado: (2011)

Bile acid nuclear receptor FXR and digestive system diseases
por: Ding, Lili, et al.
Publicado: (2015)

Fxr signaling and microbial metabolism of bile salts in the zebrafish intestine
por: Wen, Jia, et al.
Publicado: (2021)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

Role of the bile acid receptor TGR5 (Gpbar-1) in liver damage and regeneration
por: Keitel, Verena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1r6dkckpp7mhb0dvspclkm4hso